《Stem Cells International》雜志的最新年發文量為109篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在細胞與組織工程領域的學術影響力。
該刊聚焦于醫學-細胞與組織工程領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 18 Weeks 。
Stem Cells International 雜志發文統計
文章名稱引用次數
- Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment106
- Challenges and Controversies in Human Mesenchymal Stem Cell Therapy67
- Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application63
- Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering61
- Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells46
- MicroRNA- Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction43
- Advances in Regenerative Medicine and Tissue Engineering: Innovation and Transformation of Medicine32
- Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives32
- Insights into Endothelial Progenitor Cells: Origin, Classification, Potentials, and Prospects28
- Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential28
國家/地區發文量
- CHINA MAINLAND389
- USA124
- Italy84
- GERMANY (FED REP GER)74
- South Korea56
- Brazil36
- Japan36
- Australia29
- Canada28
- England25
